Graney & King’s Oracle ORCL Stock Holding History

Graney & King’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.5K	Sell	229 -67	-23%	-$12.1K	0.01%	179
2026 Q1	$43.5K	Buy	+296	New	+$48.1K	0.02%	153

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Graney & King's ORCL Position: Q2 2026 in Review

Graney & King reduced its Oracle (ORCL) stake by 23% in Q2 2026, selling an estimated $12.1K and leaving 229 shares worth $33.5K. The position accounts for 0.01% of the portfolio, ranked #179.

Graney & King first reported a position in ORCL in Q1 2026 and has held it in 2 quarters since. The position peaked at $43.5K in Q1 2026. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Graney & King held 229 shares of Oracle worth $33.5K as of Q2 2026.
Graney & King sold 67 Oracle shares in Q2 2026, an estimated $12.1K.
Oracle made up 0.01% of Graney & King's portfolio in Q2 2026, its #179 holding.
Graney & King first reported a position in Oracle in Q1 2026 and has held it in 2 quarters since.
Graney & King's Oracle position peaked at $43.5K in Q1 2026.
3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.